whatshot

DNTH   $89.34  2.20% Market Closed After Close 89.34 0.0

Dianthus Therapeutics, Inc.
show_chart Advanced Chart of DNTH

Current temperature: 0.00
ST: 0, Cor:

Analyst Recommendations:
Number of estimates 14
Target Price Mean 126.50
Mean unverified/preliminary 126.50 / 126.50
Target Price Low / High 98.00 / 200.00
Median / STD DEV 124.00 / 25.42
Tech Forecasts:
More signals
  < 1M 1-3M > 3M
total Sell Sell Sell
rsi Sell Sell Sell
macd None None None
stoch Sell None None
ma20 Sell Sell None
ma50 Sell None None
ma100 Sell Sell Sell
Candlestick PatternMay 4, 2026 Bullish Engulfing - is characterized by a large white body engulfing a preceding smaller black body, which appears during a downtrend. Considered to be a bullish reversal pattern.
ISIN US2528281080
ceo Mr. Marino Garcia M.B.A.
Website https://dianthustx.com
Dianthus Therapeutics, Inc., a clinical-stage biotechnology company, develops complement therapeutics for patients with severe autoimmune and inflammatory diseases. It is developing DNTH103, a monoclonal antibody, which is in Phase 2 clinical trial, for the treatment of generalized myasthenia gravis, multifocal motor neuropathy, and chronic inflammatory demyelinating polyneuropathy. Dianthus Therapeutics, Inc. was founded in 2019 and is headquartered in New York, New York.